BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17225840)

  • 1. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status.
    Ibrahim S; el-Din S; Bazzal I
    J Natl Med Assoc; 2006 Dec; 98(12):1953-7. PubMed ID: 17225840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
    Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
    Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi Hemodialysis Center.
    Al Saran K; Sabry A; Al Halawany Z; Ismail M
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):185-91. PubMed ID: 24434410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis].
    Pin M; Compte MT; Angelet P; Gállego C; Gutiérrez C; Martinez Vea A
    Nefrologia; 2009; 29(5):415-20. PubMed ID: 19820753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient haemodialysis improves the response to hepatitis B virus vaccination.
    Kovacic V; Sain M; Vukman V
    Intervirology; 2002; 45(3):172-6. PubMed ID: 12403922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of hepatitis B vaccine immunity in hemodialysis patients.
    Ramezani A; Velayati AA; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Ther Apher Dial; 2008 Apr; 12(2):143-6. PubMed ID: 18387163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
    Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
    Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of maternal and fetal hepatitis B antibody titers following maternal vaccination in pregnancy.
    Ingardia CJ; Kelley L; Lerer T; Wax JR; Steinfeld JD
    Am J Perinatol; 1999; 16(3):129-32. PubMed ID: 10438194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
    Chaves SS; Daniels D; Cooper BW; Malo-Schlegel S; Macarthur S; Robbins KC; Kobetitsch JF; McDaniel A; D'Avella JF; Alter MJ
    Vaccine; 2011 Dec; 29(52):9618-23. PubMed ID: 22044739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
    Lin SY; Liu JH; Lin CC; Wang SM; Tsai CA; Chou CY; Kuo HL; Wang IK; Liu YL; Lin HH; Huang CC
    Vaccine; 2011 May; 29(21):3738-41. PubMed ID: 21458609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients.
    Dacko C; Holley JL
    Adv Perit Dial; 1996; 12():315-7. PubMed ID: 8865927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
    Charest AF; McDougall J; Goldstein MB
    Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
    Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
    Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.